New research seems to confirm what has already been suspected about nonlipid biomarkers: They may be good at predicting coronary heart disease, but they are not so good at predicting the risk for major cardiovascular events. John Kastelein of the Academic Medical Center in Amsterdam, along with his colleagues, measured levels of standard lipids and 18 nonlipid biomarkers in more than 1,500 CHD patients. They also assessed the incidence of major CV events. Almost none of the nonlipid biomarkers were able to predict the major cardiovascular events. Story